Clinical Trials in Pittsburgh

Showing 6461-6480 of 21,047 trials

A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

NCT05662397

This is a Phase 1/2 study of HST-1011, a CBL-B inhibitor, being developed for the treatment of patients with advanced solid tumors, who relapsed while on or are refractory to approved anti-PD(L)1 therapies or other standard of care.

Solid Tumor, AdultRelapsed CancerRefractory Cancer

HotSpot Therapeutics, Inc77 participantsStarted Mar 2023

Sarasota, Florida, United States • Las Vegas, Nevada, United States • New York, New York, United States +11 more locations

COMPLETEDNA< 1 mile

A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students

NCT05608109

This study seeks to evaluate the unique and synergistic efficacy of social media-specific personalized normative feedback targeting the reduction of alcohol use among heavy-drinking college students who post alcohol-related content on social media. Hypothesis: Alcohol personalized normative feedback, social media-specific personalized normative feedback, and the Alcohol personalized normative feedback+ social media-specific personalized normative feedback conditions will be more effective in reducing drinking than the attention control condition.

Alcohol Consumption

Duquesne University401 participantsStarted Jan 2022

Oxford, Ohio, United States • Houston, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States

A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students

Find Trials by Condition in Pittsburgh

Establishing Efficacy of an Inpatient Intervention and Phone App to Reduce Suicidal Risk

A Study of Acute Respiratory Infections in Global Outpatient Setting

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

The ShortCut™ Study Protocol

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer

A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment

A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants